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Objective: We undertook this study to quantitate differences in the degree of calcification between symptomatic and
asymptomatic plaques removed at carotid endarterectomy (CEA) and to determine associated extent of plaque macro-
phage infiltration, a histopathologic feature of plaque instability.
Methods: CEA plaques (n  48) were imaged at 1.25-mm intervals with spiral computed tomography (CT; 10-15 images
per plaque). Indications for CEA were transient ischemic attack (n  16), stroke (n  5), amaurosis (n  4), and critical
asymptomatic stenosis (n 23). The percent area calcification for each plaque was determined in spiral CT serial sections
and averaged for each plaque. In 31 of 48 plaques macrophage infiltration was quantitated in corresponding histologic
sections with immunohistochemical techniques.
Results: The mean ( SD) age of patients with symptomatic and asymptomatic plaques was 66  7 years vs 71  7 years,
respectively, and degree of stenosis was 76% versus 82%, respectively (P  .05). Atherosclerosis risk factors were similar
between groups. Percent plaque area calcification was twofold greater in asymptomatic versus symptomatic plaques (48%
 19% vs 24%  20%, respectively; P < .05). At receiver operating characteristic curve analysis, 80% of symptomatic
plaques were below and 87% of asymptomatic plaques were above a cutoff point of 30% plaque area calcification.
Macrophage burden was greater in the symptomatic plaques than in the asymptomatic plaques (52% vs 23%; P < .03). A
strong inverse relationship between the degree of plaque calcification and macrophage infiltration was found in critical
carotid stenoses (r  0.87; P < .001).
Conclusions: Symptomatic plaques are less calcified and more inflamed than asymptomatic plaques. Regardless of clinical
outcome, a strong inverse correlation was found between the extent of carotid plaque calcification and the intensity of
plaque fibrous cap inflammation as determined by the degree of macrophage infiltration. Carotid plaque calcification is
associated with plaque stability, and is a potential spiral CT in vivo quantitative marker for cerebrovascular ischemic event
risk. (J Vasc Surg 2004;40:262-9.)Current management of symptomatic and asymptom-
atic extracranial internal carotid artery (ICA) occlusive dis-
ease is largely determined by the severity of arteriographic
ICA lumen stenosis.1-3 On the basis of North American
Symptomatic Carotid Endarterectomy Trial results, use of
carotid endarterectomy (CEA) to treat symptomatic ICA
stenoses greater than 50% is superior to best medical ther-
apy in preventing long-term cerebrovascular events. How-
ever, surgical or endovascular intervention to treat critical
asymptomatic ICA stenoses remains controversial. In the
Asymptomatic Carotid Atherosclerosis Study,3 for exam-
ple, most patients with variable degrees of ICA stenosis 60%
or greater remained asymptomatic, and the benefit of CEA
was not demonstrated in women.
These results suggest that other variables, such as
plaque structural composition, may influence the natural
history of a given ICA stenosis. The spatial distribution of
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doi:10.1016/j.jvs.2004.04.025262specific plaque components such as the necrotic core and
inflammatory foam cell distribution are conducive to ca-
rotid fibrous cap disruption and transition to a symptomatic
outcome.4 Studies of mechanisms that produce acute cor-
onary occlusion also indicate that disruption of plaques
producing 50% or less lumen stenosis is a key feature
underlying such acute ischemic events.5
A number of in vivo carotid imaging studies have demon-
strated that carotid plaque surface and structural characteris-
tics are associated with development of thromboembolic
events.6-23 B-mode ultrasound and magnetic resonance im-
aging (MRI) are being increasingly used to potentially identify
rupture-prone unstable carotid plaques. However, most of
these studies lack satisfactory correlation with a histopatho-
logic standard.24,25 To date few studies have evaluated the
role of spiral computed tomography (CT) in the assessment
of carotid plaque stability.26,27 Calcification is a prominent
structural feature of advanced atherosclerotic plaques, and
is readily detected with spiral CT. Most studies of athero-
sclerotic plaque calcification have focused on mechanisms
in calcification of the coronary arteries or human aortas and
the relation of arterial wall calcification to plaque burden28-
32; however, the role of plaque calcification in plaque
stability and predisposition to clinical events remains un-
clear. In this retrospective descriptive study we hypothe-
sized that plaque calcification is a marker of plaque stability.
We quantitated calcification area in symptomatic and asymp-
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CT assessment, and investigated the associated extent of
macrophage infiltration as a marker of plaque inflamma-
tion, a histopathologic feature of plaque instability.
METHODS
Patient population and CEA plaques. Forty-eight
carotid bifurcation plaques were collected from 48 consec-
utive patients who underwent standard semi-eversion CEA
to treat high-grade ICA stenosis. Patient mean ( SD) age
was 66  7 years and 71  7 years, respectively in the
asymptomatic and symptomatic groups, and mean carotid
percent stenosis was 82%  11% and 76%  16%, respec-
tively (P .05). Forty percent of patients in the symptom-
atic group (10 of 25) and 43% of patients in the asymptom-
atic group (10 of 23) were women (2, 0.06; P  .05). In
all patients, preoperative color duplex ultrasound scanning
of the extracranial carotid arteries was performed, and the
degree of lumen stenosis was measured with established
hemodynamic criteria.33 Arch and four-vessel arteriogra-
phy was performed in 46% of patients (22 of 48) for the
following indications: equivocal color duplex ultrasound
results due to extensive calcification or possible string sign
(n  9), severe bilateral disease (n  7), and to exclude
concomitant intracranial disease (n  6). Clinical risk fac-
tors for atherosclerosis, including coronary artery disease,
diabetes mellitus, hypertension, smoking, and hypercholes-
terolemia, were recorded for all patients.
Indications for CEA were transient ischemic attack (n
 16), stroke (n  5), amaurosis fugax (n  4), and
high-grade asymptomatic carotid stenosis (n  23). All
Fig 1. Spiral computed tomography cross-section image
area was measured with computer-assisted morphometry
range vs noncalcified regions in the 100-250 range).symptoms occurred within 6 months before endarterec-
tomy. Plaques were endarterectomized using a standard
semi-eversion technique, to enable in toto removal of the
specimen with preservation of plaque structural integrity
and to minimize possible disruption of the plaque luminal
surface.4 The harvested specimen included the distal com-
mon carotid artery plaque in continuity with the bifurca-
tion and its extension into the internal and external carotid
arteries. Among the 48 plaques available for the study, 31
plaques (16 symptomatic, 15 asymptomatic) were forma-
lin-fixed, and were available for both spiral CT and his-
topathologic studies. The remaining plaques (n 17) were
snap frozen in liquid nitrogen for future molecular analysis
of plaque structural components, and were subjected only
to spiral CT.
Ex vivo spiral CT assessment of carotid plaque
calcification. Ex vivo spiral CT imaging at 1.25-mm inter-
vals (Prospeed VX scanner, GE Medical Systems) was per-
formed on all plaques. Each plaque was imaged from the
proximal common carotid artery margin to the distal ICA.
On average, 12 cross-sectional images (range, 8-20) were
acquired for each plaque. Calcific regions of the carotid
bifurcation plaque were characterized as white radiodense
regions, in contrast to the remaining noncalcified regions of
the plaque (gray) and lumen (radiolucent-black). Spiral CT
hard copies were digitized with commercially available soft-
ware (National Institutes of Health computer software),
and the absolute calcification area for each spiral CT image
was measured with computer-assisted morphometry with
color density scale analysis (calcified regions in the 0-100
range vs noncalcified regions in the 100-250 range; Fig 1).
laques with variable degrees of calcification. Calcification
color density scale analysis (calcified regions in the 0-100s of p
with
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core image analysis laboratory by dedicated personnel
blinded to the clinical history pertaining to each plaque.
Percent area calcification for each plaque was calculated as
the ratio between the summed calcification area per section
and the summed plaque total section areas at spiral CT.
Histopathologic and histomorphometric analysis.
Thirty one plaques were available for histopathologic eval-
uation. Plaques were formalin-fixed and sectioned trans-
versely into 3-mm blocks. On average, four blocks (range,
3-7) were available for each plaque. Each block was embed-
ded in paraffin and sectioned at 5-m intervals. Adjacent
sections were stained with hematoxylin and eosin. In addi-
tion, immunohistochemical staining was used for detection
of inflammatory cell infiltration (macrophages), as de-
scribed below. The presence of atheroma, necrotic lipid
core, hemorrhage, fibrosis, calcification, thrombosis, in-
flammatory cell infiltrate, fibrous cap integrity, and ulcer-
ation (disruption) was determined in each section to enable
quantitation of percent area calcification using computer-
assisted morphometric techniques (Fig 2). This investiga-
tion focused on the quantitative aspects of calcification and
plaque inflammation rather than standard qualitative as-
sessment of plaque structural features.
Immunohistochemical analysis of plaque inflam-
mation. Immunohistochemical staining for macrophages
was carried out on paraffin-embedded sections mounted on
poly-L-lysin–coated slides, and air dried overnight. Sec-
tions were deparaffinized by immersing the slides in two
changes of xylene for 15 minutes each and then rehydrated
in 100%, 95%, and 75% ethanol for 3 minutes each. After
rehydration, sections were washed in phosphate-buffered
saline solution. Endogenous peroxidase activity was
blocked with 3.0% hydrogen peroxide. Sections were pre-
Fig 2. A, Histopathologic section of an asymptomatic
was quantitated in each section. (H&E; original magnifitreated with 10% goat serum for 20 minutes, then incu-
bated with mouse anti-human macrophage antibody (1:30
dilution) for 1 hour at 37°C. The avidin-biotin-immu-
noperoxidase method was used to identify the macro-
phages. Incubation with 0.1% 3,3-diaminobezidine and
hydrogen peroxide at room temperature for 5 to 10 min-
utes produced a brown reaction product. Sections repre-
senting each block were lightly counterstained with hema-
toxylin to visualize nuclei. In the fibrous cap regions
including shoulder, macrophages were counted in all sec-
tions of each plaque with a micrometer (American Optical
Corp) at high-power field (HPF) 200 (Fig 3). This work
was carried out by an experienced pathologist who was
blinded to all clinical data. The average number of macro-
phages counted at HPF in each section was calculated as the
macrophage count of that plaque.
Statistical analysis. For continuous demographic
variables results were expressed as mean  SD, and t tests
were used for group comparison. For categorical demo-
graphic variables, 2 tests were used for group comparison.
All morphometric data and cellular counts of macrophage
infiltration were compared between symptomatic and
asymptomatic plaques with Student t tests. Differences
were considered significant at P  .05.
To classify the asymptomatic and symptomatic groups
on the basis of percent area calcification, sensitivity, speci-
ficity, and positive and negative predictive values were
calculated with various cutoff points of percent area calcifi-
cation. A receiver operating characteristic (ROC) curve was
constructed to determine the optimal threshold value.
RESULTS
Demographic characteristics and prevalence of athero-
sclerotic risk factors in each subgroup are summarized in
e with extensive calcification. B, Region of calcification
40.) L, Lumen; Ca, calcification; FC, fibrous cap.plaqu
cation
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not different between the symptomatic and asymptomatic
groups, except for hypercholesterolemia, which occurred
more commonly in the symptomatic group (36% vs 26%; P
 .05). The mean degree of stenosis (at color duplex
ultrasound scanning) was 76% 16% and 82% 11% in the
symptomatic and asymptomatic groups, respectively (P 
.05), as determined with pulsed Doppler flow analysis and
B-mode imaging.
Spiral CT assessment of carotid plaque calcifica-
tion. On average, 12 cross-sectional images (range, 8-20)
were available for each plaque. Percent plaque area calcifi-
cation was twofold greater in the asymptomatic group
compared with the symptomatic group (48% 19% vs 24%
 20%; P  .05). Fig 4 shows the ROC curve used to
determine a calcification area threshold, which could best
differentiate symptomatic from asymptomatic plaques. A
cutoff of 30% plaque area calcification provided the greatest
sensitivity and specificity. With 30% area calcification as the
cutoff point, sensitivity was 87% and specificity was 80%.
Fig 3. Macrophage infiltration (arrowheads) in fibrous c
stained section at high-power field. (Original magnifica
NC, Necrotic core.The associated positive and negative predictive values were
80% and 87%, respectively.
Histomorphometric and immunohistochemical
analysis. One hundred fifty-two sections from the asymp-
tomatic group (n  83) and the symptomatic group (n 
64) were available for histopathologic assessment. Percent
plaque area calcification was significantly greater in the
asymptomatic plaques than in the symptomatic plaques
(47%  19% vs 22%  21%; P  .05).
Macrophage infiltration was more prevalent in symp-
tomatic plaques than in asymptomatic plaques. The mean
number of macrophages per HPF per section infiltrating
the region of the fibrous cap overlying the necrotic core was
significantly greater in the symptomatic plaque sections
compared with the asymptomatic plaque sections (297 
128 vs 148  83; P  .01). More important, a strong
inverse correlation (P  .0001) between the mean macro-
phage count and the percent area calcification was demon-
strated in both symptomatic plaques (r  	0.78) and
asymptomatic plaques (r  	0.89; Fig 5).
ion overlying the necrotic core in immunohistochemical
200.) Arrows point to immunostained macrophages.ap reg
tion
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The relevance of atherosclerotic plaque calcification to
plaque structural stability has been investigated most com-
Fig 4. Receiver operating characteristic (ROC) curve
groups on the basis of percent area calcification. Cuto
specificity.
Fig 5. Correlation between mean macrophage count and percent
area calcification was	0.78 (P  .0001) for symptomatic plaques
and	0.89 (P .0001) for asymptomatic plaques, indicative of the
strong negative association between macrophage count and per-
cent area calcification.monly in the coronary arteries. Coronary calcific deposits
detected with cardiac cinefluoroscopy31 and CT32 appear
to be associated with increased risk for coronary heart
disease. Demer et al29 proposed that regions of plaque
calcification adjacent to an inflamed soft necrotic core
predispose to plaque disruption and subsequent coronary
artery thrombo-occlusion. This may be related to increased
plaque fibrous cap peak stress at regions where hard calcific
and soft necrotic plaque regions are juxtaposed.
In carotid bifurcation plaques the presence and degree
of calcification has not heretofore been studied in relation
to other histopathologic features that underlie plaque dis-
ruption and clinical events. In this study we investigated the
association between the degree of carotid plaque calcifica-
tion and the clinical findings in patients undergoing CEA to
treat critical symptomatic and asymptomatic ICA stenoses.
The extent of fibrous cap inflammation, a known marker of
plaque instability and fibrous cap rupture, was also assessed
in relation to both spiral CT and histomorphometric quan-
titative analysis of calcification in intact CEA plaques. Our
working hypothesis is that carotid plaque calcification is
pathognomonic of plaque senescence and stability.
Evidence has suggested that atherosclerotic plaque
composition and anatomy are more important predictors of
plaque stability and clinical outcome than merely the de-
gree of vessel stenosis. Calcification is frequently encoun-
tered in atherosclerotic disease, and has been proposed as a
stabilizing and protective factor rather than a risk factor for
ifferentiating between asymptomatic and symptomatic
nt of 30% (arrows) yielded the highest sensitivity andfor d
ff poi
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been also published that details calcification in carotid
atherosclerosis.35 Over the past two decades an increasing
number of echomorphologic studies have been performed
to identify symptomatic carotid plaques. Many of these
studies indicate that echolucent and ulcerated atheroscle-
rotic plaques are associated with a higher risk for ischemic
cerebrovascular events, whereas echo-dense plaques are
more prevalent in asymptomatic plaques.36-39 Establishing
a quantitative relationship between carotid plaque calcifica-
tion and plaque instability may enable better prediction of
risk for ischemic events from a given plaque and the need
for intervention and monitoring of the effects of medical
management.
Currently available imaging, such as B-mode ultra-
sound scanning and MRI have been used to characterize
vulnerable carotid bifurcation plaques. These techniques
have promise, but are limited by lack of standard techniques
and logistic difficulties when ascertaining the degree of
carotid plaque calcification burden. In previous studies26,27
spiral CT has proved to be an accurate technique for
defining atherosclerotic plaque anatomy, particularly in
differentiating calcified from noncalcified regions of the
plaque.
In the present study we used ex vivo spiral CT to
quantitate the degree of carotid plaque calcification in 48
symptomatic and asymptomatic plaques. Spiral CT and
histomorphometric results demonstrate that the degree of
carotid plaque calcification is twofold less in symptomatic
CEA plaques compared with asymptomatic plaques, with
relatively similar degrees of ICA stenosis. Calcification oc-
cupied approximately 50% of asymptomatic plaque area,
and only 25% of symptomatic plaque area. At ROC curve
statistic analysis a cutoff point of 30% plaque area calcifica-
tion was found to discriminate between most symptomatic
and asymptomatic plaques. Eighty percent of symptomatic
plaques were below and 87% of asymptomatic plaques were
above this cuttoff point. This is the first report to provide
quantitative threshold data for differentiating symptomatic
from asymptomatic carotid plaques. Nonetheless, our re-
sults indicate that approximately 15% to 20% of CEA
plaques are classified incorrectly, based on the cutoff point
of 30% plaque area calcification. This may be related to a
number of variables, such as spatial location of the calcific
Demographic data and prevalence of atherosclerotic risk fa
All patients
(N  48)
n %
Smoking 35 73
Hypertension 34 70
Diabetes 18 38
Coronary artery disease 16 33
Peripheral artery disease 18 38
Hypercholesterolemia 15 31
NS, Not significant.region in relation to the lumen, necrotic core, and fibrous
cap, and the presence of microscopic foci of fibrous cap
disruption remote from heavily calcified regions in the
plaque. Furthermore, some plaques that are considered
asymptomatic may produce transient ischemic attacks dur-
ing sleep or silent infarcts noted on CT scans. In spite of
these potential drawbacks, these findings strongly suggest
that with progressive carotid plaque calcification there is
less likelihood for carotid plaques to disrupt and produce
symptoms.
To further elucidate the potential mechanisms under-
lying the correlation of plaque calcification with clinical
symptoms, plaque inflammatory macrophage burden was
also investigated in the current study. Although the bio-
logic events that trigger the local inflammatory response
within plaque are not fully understood, the association
between inflammation and atherogenesis is well known.
Inflammation has been suggested to have a number of key
roles, not only in initiation and progression of atheroscle-
rosis, but also as a cause of plaque rupture.40,41 Previously
a strong relationship between carotid plaque macrophage
accumulation and ischemic vascular events was shown.42,43
Macrophages release a myriad of cytokines and proteases,
such as interleukin-18, tissue factor, and matrix metallopro-
teinase-9, which are more prevalent in vulnerable and
symptomatic plaques compared with stable and asymptom-
atic plaques.44-46 Other evidence indicates co-localization
of plaque oxidized low-density lipoprotein with dense mac-
rophage infiltration, and that increased loads of oxidized
low-density lipoprotein is associated with plaque instabili-
ty.47
Our histopathologic investigations demonstrated that
the macrophage burden in the cap and shoulder region of
the plaque was significantly greater in symptomatic plaques
than in asymptomatic plaques (P  .01). More important,
a strong inverse correlation was found between the degree
of plaque calcification and quantitative measures of macro-
phage burden. These findings clearly indicate that plaque
calcification is a marker of regional plaque stability. Fur-
thermore, increased macrophage density is also associated
with plaque echolucency at B-mode ultrasound evalua-
tion.48 From a biomechanical perspective, replacement of a
juxtaluminal necrotic core with calcification greatly reduces
in symptomatic and asymptomatic groups
Symptomatic
roup (n  25)
Asymptomatic
group (n  23)
% n % P
80 15 65 NS
72 16 69 NS
40 8 35 NS
36 7 30 NS
36 11 50 NS
36 6 26 .05ctors
g
n
20
18
10
9
9
9
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risk for fibrous cap disruption.36
Future studies directed to dissecting the molecular
events that underlie plaque calcification will shed light on
the biologic triggers of this pathobiologic event. More
important, our findings suggest that prospective in vivo
quantitative assessment of carotid bifurcation plaque calci-
fication, and conceivably other arterial segments, with spiral
CT or MRI should provide additional information for in
vivo detection of asymptomatic carotid plaques that are
likely to disrupt and produce cerebrovascular ischemic
events.
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Brown, who did the original fat study, published a paper that is
concordant with your findings in ATVB 2 or 3 years ago. He took
patients from the fat study who had been on a statin for 10 or 15
years and their carotids were calcified, and he took a control group
with the same initial lipids and they had very little calcium and lots
of fat in the carotid. I think one of the implications of your findings
and his, if they can be extrapolated to coronaries, is the push for
detection of coronary calcification as an indication of something
bad going on in the coronaries. I think your study makes sense and
has important implications.
Dr Hisham S. Bassiouny. I didn’t go into the differential role
of calcification in different arterial segments. As you know, Demer
and other investigators have proposed that plaque calcification in
the coronary arterial tree is potentially deleterious because that
mismatch of mechanical properties might actually lead to plaque
disruption. Such hypotheses have yet to be proven and may not
apply to the carotid bifurcation. I think that the behavior of
coronary plaques is quite different from carotid plaques. Coronary
plaques tend to disrupt at lesser degrees of stenosis, and this may be
because of their composition and the biomechanics of the coronary
arterial tree compared with the carotid tree. I agree with you that
the question is still open for the coronary circulation, but in the
carotid bifurcation, I think that if we follow these plaques and find
that they are becoming progressively calcified, then the chance that
they will disrupt is probably small.
Dr Munier Nazzal (Toledo, Ohio). I might have missed that
in the presentation. You know, different surgeons remove different
portions of the plaque. So in which part of the plaque will you
calculate the percentage of calcification? This is the first question.
The other thing is the location of the calcification. Does it
make a difference?
Dr Bassiouny. These are two very excellent points. Again, we
have intentionally removed the plaque using the semi-eversion
technique. I personally do not cut through the plaque. I dissect the
plaque through the adventitia, then open the internal carotid artery
distally to feather it out. As you saw in one of these gross speci-
mens, there is a moderate plaque burden in the external carotid
artery, so with spiral CT analysis we do measure the calcification in
both the internal and the external carotid arteries.
With regard to your second question, the location of calcifi-
cation was not assessed in this study. It is an important aspect of any
study, as a focal area of calcification near the lumen behaves
differently from a focal area of calcification within the adventitia.
The other point is that we have outliers. We have patients who have
extensive plaque calcification and have had symptoms. There is
always the possibility that a focus remote from the area of calcifi-
cation is inflamed and exhibits fibrous cap disruption.
Dr Kirsh Soundararajam (Omaha, Neb). I just had a com-
ment. We at Creighton University have worked a little bit on theplaques of symptomatic and asymptomatic, and one of the works
was published this year in the Annals, and we did find increased
apoptosis and very thin fibrous cap. As part of the study, our
findings were also pretty consistent with increased inflammation
on symptomatic plaque. As a part of that information we also found
that when we tried to culture the endothelial cells of the symptom-
atic plaques they wouldn’t last too long. It became so clear that it
was blinded, and you get a call from the lab saying that this is
symptomatic. I said, I never told you that it is symptomatic, and it
was so evident that these are characteristically different. I just
wanted to inform you of that.
I have a couple of questions. The first one is, if you believe that
the degree of calcification reflects the stability, do you think our
concern in indication for endarterectomy should be focused more
on the echogenicity of the plaque rather than going to the degree
of stenosis of the plaque? Do you have any thoughts on that?
Dr Bassiouny. Well, that’s basically the objective of these
studies, to find out some in vivo characterization of plaque struc-
ture in addition to the degree of stenosis, which I think is a very
simplistic way of going about things, especially in asymptomatic
disease. Echolucency at ultrasound is a measure, and interestingly
enough, symptomatic plaques are more echolucent and less calci-
fied. Unfortunately, with duplex ultrasound it is challenging to
consistently resolve and quantitate plaque echolucency. It is diffi-
cult to standardize echolucency measures and techniques from lab
to lab. I think that imaging markers like calcification that can be
readily detected with spiral CT offer a more standard measure of
following asymptomatic patients, and it may be that those patients
who have asymptomatic plaques devoid of calcification represent a
subgroup of patients who may transition to symptoms and need
intervention, while the other subgroup with heavy calcification
should be left alone.
Dr Soundararajam. Were you able to categorize the degree
of inflammation to the degree of symptoms? Less inflammation,
fugax. Higher inflammation, stroke. Were you able to segregate
your group in that order?
Dr Bassiouny. It is difficult to quantitatively achieve that
goal. Symptomatic plaques had a greater number of inflamed
sections than the asymptomatic plaques. The relationship between
the degree of calcification and inflammation was inverse.
Dr Robert Cambria (Milwaukee, Wis). I have a quick simple
question. Can you assure us that the degree of stenosis in your two
groups were similar? You mentioned early on that you had different
indications in the two groups, so you need to make sure that the
degree of stenosis is similar.
Dr Bassiouny. The degree of stenosis in both groups was
similar. The asymptomatic group had a higher degree of stenosis
than the symptomatic group (82% vs 76%).
